David A. Hunstad

David A. Hunstad, MD

Specializes In
  • Infectious Diseases
Languages Spoken
  • English

Appointments

Sees Patients For

Pediatric infectious diseases, urinary tract infections, diagnostic medicine

Hospital Affiliations

  • St. Louis Children's Hospital

Locations

Experience

Board Certifications

  • Pediatric Infectious Diseases
  • Pediatrics

Academic Title(s)

Associate Professor, Pediatrics
Chief, Division of Infectious Diseases
Associate Professor, Molecular Microbiology

Research Interests

Work in our laboratory focuses on the interactions of pathogenic bacteria with their hosts. We aim to elucidate the modulation of host immune responses by pathogens and to determine the mechanisms by which these bacteria present specific virulence factors on their surfaces. Our primary goal is to discover novel targets for interventions that will prevent and treat bacterial infections of the urinary tract, gastrointestinal tract, and central nervous system.

Publications & Research

Search PubMed for publications »

Education

Residency, Pediatrics

1998 St. Louis Children's Hospital, St. Louis, MO

Chief Resident, Pediatrics

1999 St. Louis Children's Hospital, St Louis, MO

Fellowship

2003 Pediatric Infectious Diseases, Washington University School of Medicine, St. Louis MO 63110

B.A.

1991 Carleton College, Northfield, Minnesota

Medical Degree

1995 Washington University School of Medicine, St. Louis, MO

Financial Disclosures
  • Bioversys
    • Equity: Yes
    • Consulting/Advisory Board: $20,000 - $39,999
    • Reporting Date: 05/01/2021

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.